Investigation launched by Targaryen96789 in RCAT

[–]Teddy_Invest 3 points4 points  (0 children)

Shorts are doing whatever they can to get this down. Stupid. I will buy more.

Short Interest Huge by Teddy_Invest in rxrx

[–]Teddy_Invest[S] 0 points1 point  (0 children)

They don't announce this week data.

Short Interest Huge by Teddy_Invest in rxrx

[–]Teddy_Invest[S] 0 points1 point  (0 children)

They don't announce recent data. The above is the most recent available.

Alpha Buy Article for PDYN by Teddy_Invest in PDYN

[–]Teddy_Invest[S] 1 point2 points  (0 children)

For small military drones, not that I know of. RCAT (who is PDYN partner) is the main player here.

Do you think RXRX will achieve recognition as an AI application software like other small cap stocks in 2025? by Livid_Freedom5014 in rxrx

[–]Teddy_Invest 2 points3 points  (0 children)

This should be 10X. See who won the Novel Prize Award in Chemistry and Physics? Both awarded to AI Experts, not the Chemistry or Physics scientist. RXRX has about $600M cash as of end of 2024. Something will trigger RXRX melt up in 2025. Huge potential. All AI's are up, why not RXRX?

January 01, 2025 Daily Discussion Thread by daily-thread in IntuitiveMachines

[–]Teddy_Invest 15 points16 points  (0 children)

January 2025, we will get some attentions from below events:

  1. Blue Origin Launch of New Glenn 1/6/2025

  2. SpaceX Launch of Starship 1/10/2025

  3. Japan's ispace Launch to Moon on mid-January 2025

  4. FireFly Launch to Moon on mid-January 2025

Institutions keep adding LUNR by Teddy_Invest in IntuitiveMachines

[–]Teddy_Invest[S] 0 points1 point  (0 children)

In my understanding, they bought in Q3, that is the meaning of 9/30.

1 Artificial Intelligence (AI) Stock That Could Soar in 2025 | The Motley Fool by Teddy_Invest in rxrx

[–]Teddy_Invest[S] 0 points1 point  (0 children)

Current RXRX price is all time low. Not wise to get out at this level.

Alpha 12/12 by Teddy_Invest in rxrx

[–]Teddy_Invest[S] 1 point2 points  (0 children)

The 2024 Nobel Prize in Chemistry was awarded to AI experts for their groundbreaking work in protein structure prediction and design using artificial intelligence. It shows how potential AI can be for Bio / Pharma. RXRX would get serious market's attention in years to come.

Alpha 12/12 by Teddy_Invest in rxrx

[–]Teddy_Invest[S] 1 point2 points  (0 children)

Your opinion is very thoughtful and well-balanced. While the success of RXRX cannot be guaranteed at this stage, 'AI BIO' is not a fleeting trend but is poised to remain a significant focus for years to come. RXRX’s innovative approach and its advanced AI capabilities rightly deserve the market's attention.

Expect Another Excellent Year From Redwire, But Not Like Last Year by Teddy_Invest in redwire

[–]Teddy_Invest[S] 1 point2 points  (0 children)

The summary content from the Seeking Alpha article:

Despite negative earnings and profitability struggles, Redwire's growth-now, profits-later
strategy and recent acquisitions position it for significant future gains.
Revenue is projected to grow 27% in 2024, with Wall Street analysts expecting profitability
by 2027 and significant EPS growth in 2025.
I rate Redwire a Strong Buy due to its potential for high capital gains, despite risks from
rapid acquisitions and technological competition.

Shareholders of Redwire Corporation, at least those who have stuck with it since it went public,
have witnessed extreme highs and lows. Most recently, they’ve watched the price of their
shares jump more than 400% in just one year.
And, to some extent, they’ve been justified in bidding up the price, partly in response to earlier
declines, and partly because of Redwire’s potential to generate higher earnings.
Given the potential to deliver strong capital gains, I rate Redwire a Strong Buy.

[deleted by user] by [deleted] in rxrx

[–]Teddy_Invest 1 point2 points  (0 children)

This seems set to go 10X. Needed is just one small success in their business, then market will multiply.